Sean O'Donnell is an accomplished biopharmaceutical professional with over 16 years of experience in virology product research and development, including gene therapy, cell therapy, and monoclonal antibodies. Currently serving as Executive Director at Eli Lilly and Company, Sean has a strong background in establishing collaborative relationships with regulatory agencies and scientific researchers. Previous roles include senior positions at Biogen Idec, Meridian Life Science, and the National Institutes of Health, as well as postdoctoral fellowships at Vanderbilt University Medical Center. Sean earned a Ph.D. in Microbiology from Miami University and has published research in peer-reviewed journals while presenting at national and international scientific conferences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices